Breakfast session: Arrhythmia / EP: Debate: Stroke prevention in AF
Tracks
Track 2
| Saturday, August 8, 2026 |
| 7:30 AM - 8:15 AM |
Speaker
Prof Boyoung Joung
Director
Yonsei Heart Rhythm Center
Anticogulation should be stopped after successful AF ablation: For
7:30 AM - 7:45 AMBiography
Prof. Boyoung Joung is a professor of cardiology, the Director of the Yonsei Heart Rhythm Center, and Vice President of Yonsei University Severance Hospital. Prof. Joung is the principal investigator of the Korean multicenter AF registry (CODE-AF) and several clinical trials funded by the Korean Ministry of Health, including the ALONE-AF and SINGLE-AF trials. He also serves as the chairperson of the Korean AF guidelines (2018 and 2021) and the NOAC guidelines (2018 and 2022). He is currently the Vice President of the Korean Heart Rhythm Society. Prof. Joung has published more than 500 peer-reviewed articles as a principal investigator, including in JAMA, BMJ, Annals of Internal Medicine, European Heart Journal, Circulation, and the Journal of the American College of Cardiology.
He focuses on improving patient care in four principal areas: (i) generating new evidence for arrhythmia treatment and clinical guidelines; (ii) applying artificial intelligence to AF management; (iii) preventing stroke and dementia related to AF; and (iv) developing biodrugs for arrhythmia treatment.
Prof Martin Stiles
Director of Electrophysiology
University of Auckland
Anticogulation should be stopped after successful AF ablation: Against
7:45 AM - 8:00 AMBiography
Assoc Prof Sandeep Prabhu
Electrophysiologist and Senior Research Fellow
Alfred Hosptial and Baker Institute
Commentary
8:00 AM - 8:15 AMBiography
Sunny is an internationally recognised clinical researcher in the field of arrhythmia management with over 100 peer reviewed publications. He is a current holder of both the prestigious NHRMC Emerging Leader-2 Research Grant, and a National Heart Foundation Post Doctorate Scholarship. He is currently involved in a co-ordination and running of a number of clinical trials and the co-supervision of several PhD students through the Alfred Hospital and the Baker Heart and Diabetes Institute.
